Nomura Holdings Inc Theravance Biopharma, Inc. Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $2,611 - $3,889	-352 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $2,383 - $5,072	352 New	352 $3,000
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $3.47 Million - $4.99 Million	-210,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $2.34 Million - $3.77 Million	150,000 Added 250.0%	210,000 $3.56 Million
Q1 2019 May 14, 2019	BUY	$22.57 - $28.15 $1.35 Million - $1.69 Million	60,000 New	60,000 $1.41 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $665M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.